Core Scientific (CORZ) financials

Core Scientific reported revenue of $592.1M over the twelve months to Sep 30, 2026 (+187.1% year on year, latest quarter), with a 52.9% gross margin and a 31.1% operating margin in its latest quarter. Read from its own SEC filings (XBRL), each period with the filing behind it.

Quarters, as filed

Quarter endedRevenueGross profitOperating incomeNet incomeFiled
Sep 30, 2026$232.9M$123.3M$72.4M$1.2BNov 5, 2026
Jun 30, 2026$164.2M$70.0M-$78.5M-$1.2BJul 28, 2026
Mar 31, 2026$115.2M$30.1M-$310.4M-$347.2MMay 6, 2026
Dec 31, 2025$79.8M$20.8M-$117.5M$216.0MMar 2, 2026
Sep 30, 2025$81.1M$3.9M-$54.8M-$144.0MNov 5, 2026
Jun 30, 2025$78.6M$5.0M-$26.3M-$936.8MJul 28, 2026
Mar 31, 2025$79.5M$8.2M-$47.0M$576.3MMay 6, 2026
Dec 31, 2024$94.9M$4.8M-$65.4M-$291.1MMar 2, 2026

What Core Scientific expects

Core Scientific's next results are expected around Mar 1, 2027: an estimate from the release of the same quarter last year (Mar 2, 2026), plus 52 weeks, not a date the company announced.

Where Core Scientific's revenue comes from

Customers Core Scientific discloses, the quarter ended Sep 30, 2026: One Customer 93.0% of revenue (not named by the company) and One Customer 5.0% of revenue (not named by the company). 10-Q filed Nov 5, 2026

Customers named in Core Scientific's filed contracts: CoreWeave (relationships). No filing says which of them, if any, is “Customer A”.

More on Core Scientific

All tracked companies · Holders · Dividends